Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study

J Schmidt1, P Duhaut, A M Bourgeois

  • 1Department of Internal Medicine, Place Victor Pauchet, Amiens University Hospital, 80000 Amiens CEDEX 1, France. schmidt.jean@chu-amiens.fr

Abstract

Insights

Procalcitonin (PCT) levels were normal in patients with Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR), suggesting these conditions are not triggered by bacterial infections.

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Disease

Background:

  • Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) exhibit epidemic patterns.
  • Immunological studies suggest activation of dendritic cells and toll-like receptors by an unknown antigen.
  • Procalcitonin (PCT) is a known early marker for bacterial infections.

Purpose of the Study:

  • To evaluate procalcitonin (PCT) levels in patients diagnosed with GCA and PMR at disease onset.
  • To investigate the potential role of bacterial triggers in GCA and PMR pathogenesis.

Main Methods:

  • A cohort of 46 patients diagnosed between 2002-2006 was randomly selected.
  • All patients met established diagnostic criteria (ACR or Hunder).
  • Blood samples were collected prior to the initiation of steroid therapy.

Main Results:

  • Procalcitonin (PCT) levels were found to be normal in all GCA and PMR patients.
  • Slightly elevated PCT levels were observed in men compared to women (P=0.009).
  • PCT levels were higher in PMR patients compared to GCA patients (P=0.018), with no significant correlation to inflammation markers.

Conclusions:

  • The findings do not support a bacterial trigger for GCA or PMR.
  • Elevated PCT levels in patients with inflammatory syndromes and GCA/PMR symptoms, alongside a negative temporal artery biopsy, may help rule out GCA and PMR diagnoses.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...